NCT06456580Phase 3Active not recruiting

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Study sponsor: Vor Biopharma

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-03Estimated
Enrollment · participants191Actual
Source updated2026-10-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 180 participants (planned). After: 191 participants (actual).

Primary completion date changed

Before: May 2027. After: Mar 2027.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Primary completion date changed

Before: Dec 2026. After: May 2027.

Check registry source

· 1 field changed

Primary completion date changed

Before: Jul 2026. After: Dec 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview